TotalMarketCap

Quoin Pharmaceuticals

QNRXNasdaq IsraelHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$18.496 M

$3.85 -3.51%

Close of 6 Nov 2026

As of 6 Nov 2026, Quoin Pharmaceuticals (QNRX) has a market capitalization of $18.5M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$15.8M

Loss-making

Shares outstanding

70,294,615

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #385Aytu BiopharmaAYTU$19.9M
  2. #386Cocrystal PharmaCOCP$19.5M
  3. #387Quoin PharmaceuticalsQNRX$18.5M
  4. #388Actuate TherapeuticsACTU$18.4M
  5. #389Quantum BiopharmaQNTM$17.8M

What if Quoin Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.2T

$5,877,587

Per share 1,526,646× higher

Bitcoin $1.53T

$318,025.99

Per share 82,604× higher

Apple $5.02T

$1,044,050

Per share 271,182× higher

Or at a round number

$50.0M$100.0M$200.0M$500.0M

Where these numbers come from

Share counts and financials for Quoin Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.